Literature DB >> 590844

Mechanism of hypogonadism in cirrhotic males.

G R Green.   

Abstract

Men with chronic liver disease frequently develop clinical signs of hypogonadism and overt feminisation. Associated with these features, they have been found to have a reduced production of testosterone with low plasma concentrations, but only a minority of cirrhotic men would seem to have a marginal increase in circulating biologically potent oestrogens. Furthermore, this latter finding does not correlate with the presence of clinical feminisation. The original hypothesis to explain these changes now seems less likely to be true and no other single hypothesis has, on its own, been found to provide an adequate explanation for all the clinical and biochemical features found in cirrhotic men. It may be that the pathogenesis of endocrine changes in cirrhotic men is multifactorial--for instance, a combination of decreased hepatic clearance of some oestrogenic compounds, an autoimmune mediated primary testicular defect, and a specific potentiation effect by alcohol. Alternatively, it may be that none of these suggested mechanisms is of importance and that the endocrine changes are mediated instead by other mechanisms which remain, as yet, undiscovered or unconsidered. The fascination which this problem has held for clinicians and biochemists for many years seems likely to persist for some time to come.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590844      PMCID: PMC1411687          DOI: 10.1136/gut.18.10.843

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  OESTROGEN METABOLISM AND EXCRETION IN LIVER DISEASE.

Authors:  J B BROWN; G P CREAN; J GINSBURG
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

2.  SPIRONOLACTONE THERAPY AND GYNECOMASTIA.

Authors:  E CLARK
Journal:  JAMA       Date:  1965-07-12       Impact factor: 56.272

3.  Cirrhosis of the liver: a study of alcoholic and nonalcoholic patients in Boston and London.

Authors:  W H SUMMERSKILL; C S DAVIDSON; J H DIBLE; G K MALLORY; S SHERLOCK; M D TURNER; S J WOLFE
Journal:  N Engl J Med       Date:  1960-01-07       Impact factor: 91.245

4.  Comparative effectiveness of estrogens on fluid imbibition and growth of the rat's uterus.

Authors:  F L HISAW
Journal:  Endocrinology       Date:  1959-02       Impact factor: 4.736

5.  [Phenol steroid excretion in liver cirrhosis in males; fluorimetric determination].

Authors:  J MULLER
Journal:  Acta Endocrinol (Copenh)       Date:  1958-06

6.  [Estrogen metabolism disorder in liver diseases with special reference to the cause of gynecomastia].

Authors:  L GREGORIS
Journal:  Acta Med Patav       Date:  1957 Apr-Jun

7.  Hormone excretion in liver disease.

Authors:  F C DOHAN; E M RICHARDSON; L W BLUEMLE; P GYORGY
Journal:  J Clin Invest       Date:  1952-05       Impact factor: 14.808

8.  Hormonal studies in patients with chronic liver disease.

Authors:  I J PINCUS; A E RAKOFF; E M COHN; H TUMEN
Journal:  Gastroenterology       Date:  1951-12       Impact factor: 22.682

9.  Hormone excretion in liver disease and in gynecomastia.

Authors:  J RUPP; A CANTAROW; A E RAKOFF; K E PASCHKIS
Journal:  J Clin Endocrinol Metab       Date:  1951-07       Impact factor: 5.958

10.  The testis, breast and prostate of men who die of cirrhosis of the liver.

Authors:  H S BENNETT; A H BAGGENSTOSS; H R BUTT
Journal:  Am J Clin Pathol       Date:  1950-09       Impact factor: 2.493

View more
  17 in total

Review 1.  Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Authors:  Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2017-07-11       Impact factor: 3.455

2.  Source of raised serum estrogens in male rats with portal bypass.

Authors:  G C Farrell; A Koltai; M Murray
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Consumption of alcoholic beverages in adolescence and adulthood and risk of testicular germ cell tumor.

Authors:  Mary L Biggs; David R Doody; Britton Trabert; Jacqueline R Starr; Chu Chen; Stephen M Schwartz
Journal:  Int J Cancer       Date:  2016-08-16       Impact factor: 7.396

4.  Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.

Authors:  Mary K Downer; Stacey A Kenfield; Meir J Stampfer; Kathryn M Wilson; Barbra A Dickerman; Edward L Giovannucci; Eric B Rimm; Molin Wang; Lorelei A Mucci; Walter C Willett; June M Chan; Erin L Van Blarigan
Journal:  J Clin Oncol       Date:  2019-04-26       Impact factor: 44.544

5.  Alcoholic beverages and prostate cancer in a prospective US cohort study.

Authors:  Joanne L Watters; Yikyung Park; Albert Hollenbeck; Arthur Schatzkin; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2010-09-02       Impact factor: 4.897

6.  Hypogonadism is not related to the etiology of liver cirrhosis.

Authors:  S Kaymakoğlu; A Okten; Y Cakaloğlu; G Boztaş; F Beşişik; C Taşçioğlu; S Yalçin
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

7.  Endocrine aspects of liver disease.

Authors:  R G Long
Journal:  Br Med J       Date:  1980-01-26

Review 8.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

9.  Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study.

Authors:  C Bergeron; K Kovacs
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

Review 10.  Clinical pathology of alcohol.

Authors:  V Marks
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.